A detailed history of Banco Santander, S.A. transactions in Eli Lilly & CO stock. As of the latest transaction made, Banco Santander, S.A. holds 74,447 shares of LLY stock, worth $59.3 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
74,447
Previous 76,369 2.52%
Holding current value
$59.3 Million
Previous $69.1 Million 4.61%
% of portfolio
0.78%
Previous 0.86%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $1.48 Million - $1.85 Million
-1,922 Reduced 2.52%
74,447 $66 Million
Q2 2024

Jul 29, 2024

BUY
$724.87 - $909.04 $2.14 Million - $2.69 Million
2,954 Added 4.02%
76,369 $69.1 Million
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $4.74 Million - $6.34 Million
7,996 Added 12.22%
73,415 $57.1 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $137,074 - $161,592
261 Added 0.4%
65,419 $38.1 Million
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $6.37 Million - $8.79 Million
14,660 Added 29.03%
65,158 $35 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $2.77 Million - $3.7 Million
7,888 Added 18.51%
50,498 $23.7 Million
Q1 2023

May 10, 2023

BUY
$310.63 - $364.82 $3.78 Million - $4.43 Million
12,156 Added 39.92%
42,610 $14.6 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $1.25 Million - $1.45 Million
-3,883 Reduced 11.31%
30,454 $11.1 Million
Q3 2022

Nov 08, 2022

SELL
$296.48 - $337.87 $94,280 - $107,442
-318 Reduced 0.92%
34,337 $11.1 Million
Q2 2022

Jul 28, 2022

BUY
$278.73 - $327.27 $5.76 Million - $6.77 Million
20,683 Added 148.03%
34,655 $11.2 Million
Q1 2022

May 09, 2022

BUY
$234.69 - $291.66 $590,010 - $733,233
2,514 Added 21.94%
13,972 $4 Million
Q4 2021

Feb 09, 2022

SELL
$224.85 - $279.04 $637,224 - $790,799
-2,834 Reduced 19.83%
11,458 $3.17 Million
Q3 2021

Nov 08, 2021

BUY
$221.6 - $272.71 $606,519 - $746,407
2,737 Added 23.69%
14,292 $3.3 Million
Q2 2021

Jul 29, 2021

BUY
$180.55 - $233.54 $546,344 - $706,692
3,026 Added 35.48%
11,555 $2.65 Million
Q1 2021

May 10, 2021

BUY
$164.32 - $212.72 $56,361 - $72,962
343 Added 4.19%
8,529 $1.59 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $344,936 - $456,433
2,644 Added 47.71%
8,186 $1.38 Million
Q3 2020

Nov 09, 2020

BUY
$146.22 - $169.13 $479,894 - $555,084
3,282 Added 145.22%
5,542 $821,000
Q2 2020

Aug 05, 2020

SELL
$136.42 - $164.18 $45,837 - $55,164
-336 Reduced 12.94%
2,260 $371,000
Q1 2020

May 11, 2020

BUY
$119.05 - $147.35 $23,214 - $28,733
195 Added 8.12%
2,596 $360,000
Q3 2019

Nov 06, 2019

SELL
$106.79 - $116.16 $2.28 Million - $2.48 Million
-21,350 Reduced 89.89%
2,401 $269,000
Q2 2019

Aug 07, 2019

BUY
$110.79 - $129.32 $251,604 - $293,685
2,271 Added 10.57%
23,751 $2.63 Million
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $13,134 - $15,460
-118 Reduced 0.55%
21,480 $2.76 Million
Q4 2018

Feb 12, 2019

SELL
$105.9 - $118.64 $2.88 Million - $3.23 Million
-27,199 Reduced 55.74%
21,598 $2.5 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $39,323 - $49,147
-458 Reduced 0.93%
48,797 $5.24 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $296,592 - $340,395
-3,918 Reduced 7.37%
49,255 $4.2 Million
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $3.95 Million - $4.66 Million
53,173 New
53,173 $4.11 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Banco Santander, S.A. Portfolio

Follow Banco Santander, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.